Abstract
Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Current Clinical Pharmacology
Title: Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy
Volume: 4 Issue: 2
Author(s): Vardan K. Gasparyan
Affiliation:
Abstract: Optical properties of gold and silver nanoparticles are considered. Processes of preparation of these particles are described. The data presented about application of these nanoparticles in immunoagglutination assays. The features of these metals in immunoagglutination assays are compared. Application of gold nanoparticles in DNA hybridization assays is presented. Application of these metals in cell imaging and therapy is considered. Other prospective metal and semiconductor composites for application in these area are considered.
Export Options
About this article
Cite this article as:
Gasparyan K. Vardan, Gold and Silver Nanoparticles in Bioassay, Cell Visualization and Therapy, Current Clinical Pharmacology 2009; 4 (2) . https://dx.doi.org/10.2174/157488409788184954
DOI https://dx.doi.org/10.2174/157488409788184954 |
Print ISSN 1574-8847 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3938 |
Related Articles
-
A Comprehensive Overview of Colon Cancer- A Grim Reaper of the 21st Century
Current Medicinal Chemistry Protein Kinase Homology Models: Recent Developments and Results
Current Medicinal Chemistry The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Current Cancer Therapy Reviews Viral Elements Sense Tumorigenic Processes:Approaching Selective Cancer Therapy
Mini-Reviews in Medicinal Chemistry LINE-1 Methylation is Associated with an Increased Risk of Ischemic Stroke in Men
Current Neurovascular Research Role of Nitric Oxide in the Central Interferon-alpha-induced Inhibition of Gastric Acid Secretion in Rats
Current Pharmaceutical Design Mechanism-based Combinations with Pim Kinase Inhibitors in Cancer Treatments
Current Pharmaceutical Design Mass Spectrometric Imaging of the Nervous System
Current Pharmaceutical Design Fabry Disease Cardiomyopathy: from Genes to Clinical Manifestations
Current Pharmaceutical Biotechnology Editorial [ Hot Topic:Emerging Anticancer Effects of Antiresorptive Therapies (Guest Editor: Vera Hirsh)]
Anti-Cancer Agents in Medicinal Chemistry MutS Homologues hMSH4 and hMSH5: Genetic Variations, Functions, and Implications in Human Diseases
Current Genomics Inhibition of Aromatase (AR) by Benzyl Azole-Based Compounds
Letters in Drug Design & Discovery In Silico Studies towards Enhancing the Anticancer Activity of Phytochemical Phloretin Against Cancer Drug Targets
Current Drug Therapy Unexpected High Levels of Vorinostat when Combined with Vinorelbine in Patients with Advanced Cancer
Current Clinical Pharmacology The Complex Dynamics of Breast Cancer
Current Women`s Health Reviews Discovery and ADMET: Where Are We Now
Current Topics in Medicinal Chemistry Nucleoprotein-Derived and Unbound Ribonucleosides: Bioactivity and Potential Applications
Current Pharmaceutical Design PPAR Ligands Containing Stilbene Scaffold
Mini-Reviews in Medicinal Chemistry New Indications for Established Drugs: Combined Tumor-Stroma-Targeted Cancer Therapy with PPARγ Agonists, COX-2 Inhibitors, mTOR Antagonists and Metronomic Chemotherapy
Current Cancer Drug Targets Bone Metastases Radiopharmaceuticals: An Overview
Current Radiopharmaceuticals